Science & Technology
(U99)
990 on File
WASHINGTON FOUNDATION FOR MOLECULAR PHARMACOLOGY
Financial strength (30%)
90/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$5K
Total Revenue
$8K
Total Expenses
$98K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.9%
Fundraising Efficiency
N/A
Operating Reserve
143.27x
Liability-to-Asset
0.0%
Revenue Diversification
80.1%
Executive Compensation
$0
Compared with Peers
FY 2024
Compared with 540 similar organizations
(United States, Science & Technology, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.9% | 80.8% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
143.3 mo | 27.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
80.1% | 99.7% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
85.2% | 2.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-25.8% | -1.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-52.3% | 13.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $5K | $8K | $98K | 86.9% | — |
| 2023 | $3K | $11K | $101K | 133.2% | — |
| 2022 | $7K | $8K | $109K | 80.2% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.